Pharma/Biopharma

Scientists have the first evidence that the transcription factor BRN4 is amplified and overexpressed in patients with the rare but increasing neuroendocrine prostate cancer
| 3 min read

Scientists have the first evidence that the transcription factor BRN4 is amplified and overexpressed in patients with the rare but increasing neuroendocrine prostate cancer